Global Cardiac Marker Testing Market Size, Share & Industry Trends Analysis Report By Disease, By End User, By Product (Reagents & Kits and Instruments), By Biomarker Type, By Regional Outlook and Forecast, 2022 - 2028

The Global Cardiac Marker Testing Market size is expected to reach $8.1 billion by 2028, rising at a market growth of 8.3% CAGR during the forecast period.

Protein molecules known as cardiac biomarkers are released into the blood following heart injury or heart stress. These biomarkers may be used to identify a number of cardiovascular disorders (CVD), such as acute coronary syndrome, cardiac ischemia, congestive heart failure, and myocardial infarction (ACS). The doctor can assess a patient's risk of contracting such conditions using cardiac biomarker tests.

Chemicals known as cardiac markers are released into the blood by the stressed or wounded heart. Acute coronary syndrome (ACS) and cardiac ischemia, disorders linked with insufficient blood supply to the heart, are diagnosed with the use of measurements of these biomarkers. Tests for cardiac biomarkers can also be employed to assess a person's likelihood of developing these diseases as well as to monitor and treat someone who has myocardial ischemia and probable ACS.

The development of plaque in artery walls and arterial hardening are typically the primary causes of both ACS as well as cardiac ischemia. This may lead to an abrupt obstruction of blood flow through these coronary arteries or a significant constriction of the arteries leading to the heart.

Troponin is the currently preferred biomarker test for identifying heart injury. In other circumstances, such as skeletal muscle injury, additional cardiac biomarkers may be raised and are less specific for the heart. The diagnosis, risk assessment, and treatment of patients with suspected acute coronary syndrome (ACS), acute heart failure, pulmonary embolism, and other disease states, as well as the prognosis for patients with these disorders, all rely on cardiac signs.

COVID-19 Impact Analysis

The cardiac markers testing market is anticipated to continue to benefit from the COVID-19 pandemic's effects. This is due to an increase in COVID-19 patients who have preexisting medical conditions, including cardiovascular illnesses and other conditions. Since there are more heart attacks in these patients with pre-existing medical disorders like cardiovascular disease, Troponin levels were also thought to be significantly greater in COVID-19 patients who passed away or were in critical condition. For patients with COVID-19, this has increased the demand for cardiac biomarker testing. Thus, taking into consideration all of these variables, the market for cardiac markers testing shows significant growth throughout this pandemic and is anticipated to increase further.

Market Growth Factors

Rising Prevalence Of Cardiovascular Diseases

Numerous diseases and disorders are on the rise as people's lifestyles transform rapidly around the world. Lifestyle changes can lead to major health problems, including cardiovascular disease. An unhealthy diet, lack of physical activity, tobacco use, and excessive alcohol consumption are the primary modifiable risk factors for cardiovascular disease and stroke. Symptoms including hypertension, abnormal lipid profiles, diabetes, and obesity can all be attributed to a person's lifestyle choices.

Growth Of Healthcare Spending

One major factor increasing access to cardiac markers testing is the developing healthcare systems of various countries across the world. As a result of the increase in cancers diseases, and other disorders, governments around the world are investing more time and money into their healthcare systems. In addition, the healthcare industry is being pushed to adapt to new challenges by the ongoing pandemic, which continues to demand the attention and resources of healthcare systems around the world.

Market Restraining Factors

Technical Issues With Sample Storage & Collecting

For the purpose of carrying out research into the various stages that diseases can progress through in humans, epidemiology studies make use of cardiac biomarkers. In order to extract a significant quantity of knowledge from a small number of biological samples, this method necessitates the careful processing and long-term storage of these samples. It is imperative that these samples undergo a thorough quality check in order to ensure the appropriate conditions for storage and prevent the loss of data.

Product Outlook

Based on products, the cardiac marker testing market is segmented into reagents & kits and instruments. The instruments segment acquired a substantial revenue share in the cardiac marker testing market in 2021. To help identify the occurrence of ACS as well as cardiac ischemia and to assess their severity, cardiac biomarker tests are prescribed. A person with ACS or cardiac ischemia can be identified by rises in one or even more cardiac markers in the blood, enabling a quick and precise diagnosis and the right course of therapy.

Biomarker Type Outlook

On the basis of biomarker type, the cardiac marker testing market is fragmented into Troponin I & T, creatine kinase-MB(CK-MB), natriuretic peptide (Bnp Or Nt-Probnp), myoglobin, high-sensitivity C-reactive protein(hs-CRP), and other cardiac biomarkers. In 2021, the troponin I & T segment held the largest revenue share in the cardiac marker testing market. Due to its better sensitivity and specificity, cardiac troponin is the preferred biomarker again for the diagnosis of acute myocardial infarction. Recently, a number of high-sensitivity troponin tests have been introduced to the market.

Disease Outlook

By disease, the cardiac marker testing market is divided into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and ischemia. In 2021, the acute coronary syndrome segment registered a substantial revenue share in the cardiac marker testing market. This is due to the rapidly increasing illness burden in poor and medium-income countries relative to high-income countries.

End User Outlook

Based on end user, the cardiac marker testing market is classified into laboratory testing facilities, point of care testing facilities and academic institutions. In 2021, the laboratory testing segment generated the maximum revenue share in the cardiac marker testing market. This growth is attributable to factors such as the reform in healthcare infrastructure, the rise in healthcare spending, the rise in spending power, and initiatives for preventing heart attacks.

Cardiac Marker Testing Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 4.7 Billion
Market size forecast in 2028	USD 8.1 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 8.3% from 2022 to 2028
Number of Pages	303
Number of Tables	483
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Companies Strategic Developments, Company Profiling
Segments covered	Disease, Product, Biomarker Type, End User, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Rising Prevalence Of Cardiovascular Diseases Growth Of Healthcare Spending
Restraints	Technical Issues With Sample Storage & Collecting

Regional Outlook

Region wise, the cardiac marker testing market is analyzed across North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region led the cardiac marker testing market with the highest revenue share. Several factors contribute to this which include, substantial investment in research and development, the presence of key players and ready access to their products, and a mature healthcare system in the region.

Free Valuable Insights: Global Cardiac Marker Testing Market size to reach USD 8.1 Billion by 2028

KBV Cardinal Matrix - Cardiac Marker Testing Market Competition Analysis

The major strategies followed by the market participants are Product Launches. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd. is the major forerunner in the Cardiac Marker Testing Market. Companies such as Abbott Laboratories, Thermo Fisher Scientific, Inc. and Danaher Corporation are some of the key innovators in Cardiac Marker Testing Market.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG (Siemens AG), PerkinElmer, Inc., BioMérieux S.A., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., and DiaSorin S.p.A.

Strategies deployed in Cardiac Marker Testing Market

• Sep-2022: Abbott introduced Amplatzer Talisman patent foramen ovale. This launch aimed to address patients with PFO who are at risk of having a stroke. The launch would enhance the ease to use along with reducing time for doctors.
• Aug-2022: Bio-Rad acquired Curiosity Diagnostics, a late-stage, pre-commercial platform company. This acquisition aimed at working closely to bring the latest generation of rapid PCR systems to market. Curiosity’s PCR platform, PCR|ONE would offer a streamlined workflow as well as rapid turnaround times and is predicted to extend its reach beyond high-complexity labs into near-patient molecular diagnostics labs.
• Apr-2022: PerkinElmer expanded its existing vivo imaging portfolio by introducing Vega, a kind ultrasound platform that combines hands-free, automated technology. This expansion aimed at accelerating non-invasive research & drug development studies of liver, cancer, and kidney disease, cardiology, and more.
• Apr-2022: Roche expanded its existing cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP) portfolio by releasing the five additional uses of these cardiac biomarkers. The latest features would add real value for clinicians by supporting cardiac risk identification and enhancing diagnosis.
• Apr-2021: Siemens Healthineers' signed an agreement with Biognosys, a leader in next-generation proteomics solutions for drug discovery and development. Under this agreement, Biognosys’ expertise in unbiased biomarker discovery solutions and technologies would be combined with Siemens Healthineers’ biomarker assay development, lab testing, and commercialization capabilities. The agreement aimed at accelerating diagnostic protein biomarkers discovery and assay development.
• Mar-2021: Thermo Fisher Scientific collaborated with Mayo Clinic, a nonprofit American academic medical center. This collaboration focused on accelerating clinical validation & commercialization of certain next-generation sequencing (NGS), mass spectrometry, and immunology diagnostic tools. This acquisition would leverage NGS, mass spectrometry, and immunology technologies to enhance hematology, oncology, allergy, and autoimmunity diagnostics.
• Feb-2021: Thermo Fisher Scientific acquired Mesa Biotech, a healthcare test, and data company. The acquisition aimed at rapidly scaling manufacturing volume, driving cost efficiencies as well as bringing much-needed diagnostics to market faster and at an expanded scale.
• Sep-2020: Siemens Healthineers teamed up with Novartis Pharma AG, a global healthcare company. Under this collaboration, the companies would develop, design, and commercialize diagnostic tests for therapeutic products across Novartis’ therapeutic pipeline. Through this collaboration, the company further focused on yielding innovative diagnostic solutions to address critical unmet clinical needs. The collaboration aimed at leveraging Siemens Healthineers’ expertise in the development of innovative clinical diagnostic solutions.
• Oct-2019: Siemens Healthineers took over Corindus Vascular Robotics, a global technology leader in robotic-assisted vascular interventions. The acquisition would open up a new field for its advanced therapies business, tapping into adjacent growth markets with great potential in the upcoming years. With this acquisition, the company aimed at transforming healthcare delivery to provide better care at a lower cost.
• Sep-2019: Abbott unveiled ARCHITECT STAT; high sensitivity Troponin-I blood test. By this launch, U.S. doctors would be able to utilize this proven technology to help detect heart attacks faster with more accuracy than contemporary troponin tests.
• Jul-2018: Siemens Healthineers launched two latest assays for quick acute myocardial infarction or heart attack diagnosis. The launch would support testing initiatives by using data to accurately triage patients early or rule out myocardial infarctions.
• Apr-2018: BioMérieux signed an agreement to acquire Astute Medical, a company dedicated to improving the diagnosis of high-risk medical conditions and diseases. By this acquisition, BioMérieux would develop the NEPHROCHECK test, an FDA-cleared test based on the level of two biomarkers, IGFBP-7 and TIMP-2. The latest test would enable early risk assessment of AKI, a reduction in the occurrence of moderate to severe AKI following cardiac surgery.

Scope of the Study

Market Segments Covered in the Report:

By Disease

• Myocardial Infarction
• Congestive Heart Failure
• Atherosclerosis
• Acute Coronary Syndrome
• Ischemia

By End User

• Laboratory Testing Facilities
• Point-of-Care Testing Facilities
• Academic Institutions

By Product

• Reagents & Kits
• Instruments

By Biomarker Type

• Troponin I & T
• Creatine kinase-MB(CK-MB)
• Natriuretic peptide (Bnp Or Nt-Probnp)
• Myoglobin
• High-sensitivity C-reactive protein(hs-CRP)
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• F. Hoffmann-La Roche Ltd.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG (Siemens AG)
• PerkinElmer, Inc.
• BioMérieux S.A.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific, Inc.
• DiaSorin S.p.A.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Cardiac Marker Testing Market, by Disease
1.4.2 Global Cardiac Marker Testing Market, by End User
1.4.3 Global Cardiac Marker Testing Market, by Product
1.4.4 Global Cardiac Marker Testing Market, by Biomarker Type
1.4.5 Global Cardiac Marker Testing Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Trails & Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)

Chapter 4. Global Cardiac Marker Testing Market by Disease
4.1 Global Myocardial Infarction Market by Region
4.2 Global Congestive Heart Failure Market by Region
4.3 Global Atherosclerosis Market by Region
4.4 Global Acute Coronary Syndrome Market by Region
4.5 Global Ischemia Market by Region

Chapter 5. Global Cardiac Marker Testing Market by End User
5.1 Global Laboratory Testing Facilities Market by Region
5.2 Global Point-of-Care Testing Facilities Market by Region
5.3 Global Academic Institutions Market by Region

Chapter 6. Global Cardiac Marker Testing Market by Product
6.1 Global Reagents & Kits Market by Region
6.2 Global Instruments Market by Region

Chapter 7. Global Cardiac Marker Testing Market by Biomarker Type
7.1 Global Troponin I & T Market by Region
7.2 Global Creatine kinase-MB(CK-MB) Market by Region
7.3 Global Natriuretic peptide (Bnp Or Nt-Probnp) Market by Region
7.4 Global Myoglobin Market by Region
7.5 Global High-sensitivity C-reactive protein(hs-CRP) Market by Region
7.6 Global Others Market by Region

Chapter 8. Global Cardiac Marker Testing Market by Region
8.1 North America Cardiac Marker Testing Market
8.1.1 North America Cardiac Marker Testing Market by Disease
8.1.1.1 North America Myocardial Infarction Market by Country
8.1.1.2 North America Congestive Heart Failure Market by Country
8.1.1.3 North America Atherosclerosis Market by Country
8.1.1.4 North America Acute Coronary Syndrome Market by Country
8.1.1.5 North America Ischemia Market by Country
8.1.2 North America Cardiac Marker Testing Market by End User
8.1.2.1 North America Laboratory Testing Facilities Market by Country
8.1.2.2 North America Point-of-Care Testing Facilities Market by Country
8.1.2.3 North America Academic Institutions Market by Country
8.1.3 North America Cardiac Marker Testing Market by Product
8.1.3.1 North America Reagents & Kits Market by Country
8.1.3.2 North America Instruments Market by Country
8.1.4 North America Cardiac Marker Testing Market by Biomarker Type
8.1.4.1 North America Troponin I & T Market by Country
8.1.4.2 North America Creatine kinase-MB(CK-MB) Market by Country
8.1.4.3 North America Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
8.1.4.4 North America Myoglobin Market by Country
8.1.4.5 North America High-sensitivity C-reactive protein(hs-CRP) Market by Country
8.1.4.6 North America Others Market by Country
8.1.5 North America Cardiac Marker Testing Market by Country
8.1.5.1 US Cardiac Marker Testing Market
8.1.5.1.1 US Cardiac Marker Testing Market by Disease
8.1.5.1.2 US Cardiac Marker Testing Market by End User
8.1.5.1.3 US Cardiac Marker Testing Market by Product
8.1.5.1.4 US Cardiac Marker Testing Market by Biomarker Type
8.1.5.2 Canada Cardiac Marker Testing Market
8.1.5.2.1 Canada Cardiac Marker Testing Market by Disease
8.1.5.2.2 Canada Cardiac Marker Testing Market by End User
8.1.5.2.3 Canada Cardiac Marker Testing Market by Product
8.1.5.2.4 Canada Cardiac Marker Testing Market by Biomarker Type
8.1.5.3 Mexico Cardiac Marker Testing Market
8.1.5.3.1 Mexico Cardiac Marker Testing Market by Disease
8.1.5.3.2 Mexico Cardiac Marker Testing Market by End User
8.1.5.3.3 Mexico Cardiac Marker Testing Market by Product
8.1.5.3.4 Mexico Cardiac Marker Testing Market by Biomarker Type
8.1.5.4 Rest of North America Cardiac Marker Testing Market
8.1.5.4.1 Rest of North America Cardiac Marker Testing Market by Disease
8.1.5.4.2 Rest of North America Cardiac Marker Testing Market by End User
8.1.5.4.3 Rest of North America Cardiac Marker Testing Market by Product
8.1.5.4.4 Rest of North America Cardiac Marker Testing Market by Biomarker Type
8.2 Europe Cardiac Marker Testing Market
8.2.1 Europe Cardiac Marker Testing Market by Disease
8.2.1.1 Europe Myocardial Infarction Market by Country
8.2.1.2 Europe Congestive Heart Failure Market by Country
8.2.1.3 Europe Atherosclerosis Market by Country
8.2.1.4 Europe Acute Coronary Syndrome Market by Country
8.2.1.5 Europe Ischemia Market by Country
8.2.2 Europe Cardiac Marker Testing Market by End User
8.2.2.1 Europe Laboratory Testing Facilities Market by Country
8.2.2.2 Europe Point-of-Care Testing Facilities Market by Country
8.2.2.3 Europe Academic Institutions Market by Country
8.2.3 Europe Cardiac Marker Testing Market by Product
8.2.3.1 Europe Reagents & Kits Market by Country
8.2.3.2 Europe Instruments Market by Country
8.2.4 Europe Cardiac Marker Testing Market by Biomarker Type
8.2.4.1 Europe Troponin I & T Market by Country
8.2.4.2 Europe Creatine kinase-MB(CK-MB) Market by Country
8.2.4.3 Europe Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
8.2.4.4 Europe Myoglobin Market by Country
8.2.4.5 Europe High-sensitivity C-reactive protein(hs-CRP) Market by Country
8.2.4.6 Europe Others Market by Country
8.2.5 Europe Cardiac Marker Testing Market by Country
8.2.5.1 Germany Cardiac Marker Testing Market
8.2.5.1.1 Germany Cardiac Marker Testing Market by Disease
8.2.5.1.2 Germany Cardiac Marker Testing Market by End User
8.2.5.1.3 Germany Cardiac Marker Testing Market by Product
8.2.5.1.4 Germany Cardiac Marker Testing Market by Biomarker Type
8.2.5.2 UK Cardiac Marker Testing Market
8.2.5.2.1 UK Cardiac Marker Testing Market by Disease
8.2.5.2.2 UK Cardiac Marker Testing Market by End User
8.2.5.2.3 UK Cardiac Marker Testing Market by Product
8.2.5.2.4 UK Cardiac Marker Testing Market by Biomarker Type
8.2.5.3 France Cardiac Marker Testing Market
8.2.5.3.1 France Cardiac Marker Testing Market by Disease
8.2.5.3.2 France Cardiac Marker Testing Market by End User
8.2.5.3.3 France Cardiac Marker Testing Market by Product
8.2.5.3.4 France Cardiac Marker Testing Market by Biomarker Type
8.2.5.4 Russia Cardiac Marker Testing Market
8.2.5.4.1 Russia Cardiac Marker Testing Market by Disease
8.2.5.4.2 Russia Cardiac Marker Testing Market by End User
8.2.5.4.3 Russia Cardiac Marker Testing Market by Product
8.2.5.4.4 Russia Cardiac Marker Testing Market by Biomarker Type
8.2.5.5 Spain Cardiac Marker Testing Market
8.2.5.5.1 Spain Cardiac Marker Testing Market by Disease
8.2.5.5.2 Spain Cardiac Marker Testing Market by End User
8.2.5.5.3 Spain Cardiac Marker Testing Market by Product
8.2.5.5.4 Spain Cardiac Marker Testing Market by Biomarker Type
8.2.5.6 Italy Cardiac Marker Testing Market
8.2.5.6.1 Italy Cardiac Marker Testing Market by Disease
8.2.5.6.2 Italy Cardiac Marker Testing Market by End User
8.2.5.6.3 Italy Cardiac Marker Testing Market by Product
8.2.5.6.4 Italy Cardiac Marker Testing Market by Biomarker Type
8.2.5.7 Rest of Europe Cardiac Marker Testing Market
8.2.5.7.1 Rest of Europe Cardiac Marker Testing Market by Disease
8.2.5.7.2 Rest of Europe Cardiac Marker Testing Market by End User
8.2.5.7.3 Rest of Europe Cardiac Marker Testing Market by Product
8.2.5.7.4 Rest of Europe Cardiac Marker Testing Market by Biomarker Type
8.3 Asia Pacific Cardiac Marker Testing Market
8.3.1 Asia Pacific Cardiac Marker Testing Market by Disease
8.3.1.1 Asia Pacific Myocardial Infarction Market by Country
8.3.1.2 Asia Pacific Congestive Heart Failure Market by Country
8.3.1.3 Asia Pacific Atherosclerosis Market by Country
8.3.1.4 Asia Pacific Acute Coronary Syndrome Market by Country
8.3.1.5 Asia Pacific Ischemia Market by Country
8.3.2 Asia Pacific Cardiac Marker Testing Market by End User
8.3.2.1 Asia Pacific Laboratory Testing Facilities Market by Country
8.3.2.2 Asia Pacific Point-of-Care Testing Facilities Market by Country
8.3.2.3 Asia Pacific Academic Institutions Market by Country
8.3.3 Asia Pacific Cardiac Marker Testing Market by Product
8.3.3.1 Asia Pacific Reagents & Kits Market by Country
8.3.3.2 Asia Pacific Instruments Market by Country
8.3.4 Asia Pacific Cardiac Marker Testing Market by Biomarker Type
8.3.4.1 Asia Pacific Troponin I & T Market by Country
8.3.4.2 Asia Pacific Creatine kinase-MB(CK-MB) Market by Country
8.3.4.3 Asia Pacific Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
8.3.4.4 Asia Pacific Myoglobin Market by Country
8.3.4.5 Asia Pacific High-sensitivity C-reactive protein(hs-CRP) Market by Country
8.3.4.6 Asia Pacific Others Market by Country
8.3.5 Asia Pacific Cardiac Marker Testing Market by Country
8.3.5.1 China Cardiac Marker Testing Market
8.3.5.1.1 China Cardiac Marker Testing Market by Disease
8.3.5.1.2 China Cardiac Marker Testing Market by End User
8.3.5.1.3 China Cardiac Marker Testing Market by Product
8.3.5.1.4 China Cardiac Marker Testing Market by Biomarker Type
8.3.5.2 Japan Cardiac Marker Testing Market
8.3.5.2.1 Japan Cardiac Marker Testing Market by Disease
8.3.5.2.2 Japan Cardiac Marker Testing Market by End User
8.3.5.2.3 Japan Cardiac Marker Testing Market by Product
8.3.5.2.4 Japan Cardiac Marker Testing Market by Biomarker Type
8.3.5.3 India Cardiac Marker Testing Market
8.3.5.3.1 India Cardiac Marker Testing Market by Disease
8.3.5.3.2 India Cardiac Marker Testing Market by End User
8.3.5.3.3 India Cardiac Marker Testing Market by Product
8.3.5.3.4 India Cardiac Marker Testing Market by Biomarker Type
8.3.5.4 South Korea Cardiac Marker Testing Market
8.3.5.4.1 South Korea Cardiac Marker Testing Market by Disease
8.3.5.4.2 South Korea Cardiac Marker Testing Market by End User
8.3.5.4.3 South Korea Cardiac Marker Testing Market by Product
8.3.5.4.4 South Korea Cardiac Marker Testing Market by Biomarker Type
8.3.5.5 Singapore Cardiac Marker Testing Market
8.3.5.5.1 Singapore Cardiac Marker Testing Market by Disease
8.3.5.5.2 Singapore Cardiac Marker Testing Market by End User
8.3.5.5.3 Singapore Cardiac Marker Testing Market by Product
8.3.5.5.4 Singapore Cardiac Marker Testing Market by Biomarker Type
8.3.5.6 Malaysia Cardiac Marker Testing Market
8.3.5.6.1 Malaysia Cardiac Marker Testing Market by Disease
8.3.5.6.2 Malaysia Cardiac Marker Testing Market by End User
8.3.5.6.3 Malaysia Cardiac Marker Testing Market by Product
8.3.5.6.4 Malaysia Cardiac Marker Testing Market by Biomarker Type
8.3.5.7 Rest of Asia Pacific Cardiac Marker Testing Market
8.3.5.7.1 Rest of Asia Pacific Cardiac Marker Testing Market by Disease
8.3.5.7.2 Rest of Asia Pacific Cardiac Marker Testing Market by End User
8.3.5.7.3 Rest of Asia Pacific Cardiac Marker Testing Market by Product
8.3.5.7.4 Rest of Asia Pacific Cardiac Marker Testing Market by Biomarker Type
8.4 LAMEA Cardiac Marker Testing Market
8.4.1 LAMEA Cardiac Marker Testing Market by Disease
8.4.1.1 LAMEA Myocardial Infarction Market by Country
8.4.1.2 LAMEA Congestive Heart Failure Market by Country
8.4.1.3 LAMEA Atherosclerosis Market by Country
8.4.1.4 LAMEA Acute Coronary Syndrome Market by Country
8.4.1.5 LAMEA Ischemia Market by Country
8.4.2 LAMEA Cardiac Marker Testing Market by End User
8.4.2.1 LAMEA Laboratory Testing Facilities Market by Country
8.4.2.2 LAMEA Point-of-Care Testing Facilities Market by Country
8.4.2.3 LAMEA Academic Institutions Market by Country
8.4.3 LAMEA Cardiac Marker Testing Market by Product
8.4.3.1 LAMEA Reagents & Kits Market by Country
8.4.3.2 LAMEA Instruments Market by Country
8.4.4 LAMEA Cardiac Marker Testing Market by Biomarker Type
8.4.4.1 LAMEA Troponin I & T Market by Country
8.4.4.2 LAMEA Creatine kinase-MB(CK-MB) Market by Country
8.4.4.3 LAMEA Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country
8.4.4.4 LAMEA Myoglobin Market by Country
8.4.4.5 LAMEA High-sensitivity C-reactive protein(hs-CRP) Market by Country
8.4.4.6 LAMEA Others Market by Country
8.4.5 LAMEA Cardiac Marker Testing Market by Country
8.4.5.1 Brazil Cardiac Marker Testing Market
8.4.5.1.1 Brazil Cardiac Marker Testing Market by Disease
8.4.5.1.2 Brazil Cardiac Marker Testing Market by End User
8.4.5.1.3 Brazil Cardiac Marker Testing Market by Product
8.4.5.1.4 Brazil Cardiac Marker Testing Market by Biomarker Type
8.4.5.2 Argentina Cardiac Marker Testing Market
8.4.5.2.1 Argentina Cardiac Marker Testing Market by Disease
8.4.5.2.2 Argentina Cardiac Marker Testing Market by End User
8.4.5.2.3 Argentina Cardiac Marker Testing Market by Product
8.4.5.2.4 Argentina Cardiac Marker Testing Market by Biomarker Type
8.4.5.3 UAE Cardiac Marker Testing Market
8.4.5.3.1 UAE Cardiac Marker Testing Market by Disease
8.4.5.3.2 UAE Cardiac Marker Testing Market by End User
8.4.5.3.3 UAE Cardiac Marker Testing Market by Product
8.4.5.3.4 UAE Cardiac Marker Testing Market by Biomarker Type
8.4.5.4 Saudi Arabia Cardiac Marker Testing Market
8.4.5.4.1 Saudi Arabia Cardiac Marker Testing Market by Disease
8.4.5.4.2 Saudi Arabia Cardiac Marker Testing Market by End User
8.4.5.4.3 Saudi Arabia Cardiac Marker Testing Market by Product
8.4.5.4.4 Saudi Arabia Cardiac Marker Testing Market by Biomarker Type
8.4.5.5 South Africa Cardiac Marker Testing Market
8.4.5.5.1 South Africa Cardiac Marker Testing Market by Disease
8.4.5.5.2 South Africa Cardiac Marker Testing Market by End User
8.4.5.5.3 South Africa Cardiac Marker Testing Market by Product
8.4.5.5.4 South Africa Cardiac Marker Testing Market by Biomarker Type
8.4.5.6 Nigeria Cardiac Marker Testing Market
8.4.5.6.1 Nigeria Cardiac Marker Testing Market by Disease
8.4.5.6.2 Nigeria Cardiac Marker Testing Market by End User
8.4.5.6.3 Nigeria Cardiac Marker Testing Market by Product
8.4.5.6.4 Nigeria Cardiac Marker Testing Market by Biomarker Type
8.4.5.7 Rest of LAMEA Cardiac Marker Testing Market
8.4.5.7.1 Rest of LAMEA Cardiac Marker Testing Market by Disease
8.4.5.7.2 Rest of LAMEA Cardiac Marker Testing Market by End User
8.4.5.7.3 Rest of LAMEA Cardiac Marker Testing Market by Product
8.4.5.7.4 Rest of LAMEA Cardiac Marker Testing Market by Biomarker Type

Chapter 9. Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Product Launches and Product Expansions:
9.1.5.2 Approvals and Trials:
9.1.6 SWOT Analysis
9.2 Siemens Healthineers AG (Siemens AG)
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.5.3 Acquisition and Mergers:
9.2.6 SWOT Analysis
9.3 Becton, Dickinson and Company
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 F. Hoffmann-La Roche Ltd.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 Thermo Fisher Scientific, Inc.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Acquisition and Mergers:
9.6 Bio-Rad laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.6.5 Recent strategies and developments:
9.6.5.1 Acquisition and Mergers:
9.7 Danaher Corporation
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 DiaSorin S.p.A.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Research & Development Expenses
9.9 PerkinElmer, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Product Launches and Product Expansions:
9.10. BioMérieux S.A.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:

TABLE 1 Global Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 2 Global Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cardiac Marker Testing Market
TABLE 4 Product Launches And Product Expansions– Cardiac Marker Testing Market
TABLE 5 Acquisition and Mergers– Cardiac Marker Testing Market
TABLE 6 Acquisition and Mergers– Cardiac Marker Testing Market
TABLE 7 Global Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 8 Global Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 9 Global Myocardial Infarction Market by Region, 2018 - 2021, USD Million
TABLE 10 Global Myocardial Infarction Market by Region, 2022 - 2028, USD Million
TABLE 11 Global Congestive Heart Failure Market by Region, 2018 - 2021, USD Million
TABLE 12 Global Congestive Heart Failure Market by Region, 2022 - 2028, USD Million
TABLE 13 Global Atherosclerosis Market by Region, 2018 - 2021, USD Million
TABLE 14 Global Atherosclerosis Market by Region, 2022 - 2028, USD Million
TABLE 15 Global Acute Coronary Syndrome Market by Region, 2018 - 2021, USD Million
TABLE 16 Global Acute Coronary Syndrome Market by Region, 2022 - 2028, USD Million
TABLE 17 Global Ischemia Market by Region, 2018 - 2021, USD Million
TABLE 18 Global Ischemia Market by Region, 2022 - 2028, USD Million
TABLE 19 Global Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 20 Global Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 21 Global Laboratory Testing Facilities Market by Region, 2018 - 2021, USD Million
TABLE 22 Global Laboratory Testing Facilities Market by Region, 2022 - 2028, USD Million
TABLE 23 Global Point-of-Care Testing Facilities Market by Region, 2018 - 2021, USD Million
TABLE 24 Global Point-of-Care Testing Facilities Market by Region, 2022 - 2028, USD Million
TABLE 25 Global Academic Institutions Market by Region, 2018 - 2021, USD Million
TABLE 26 Global Academic Institutions Market by Region, 2022 - 2028, USD Million
TABLE 27 Global Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 28 Global Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 29 Global Reagents & Kits Market by Region, 2018 - 2021, USD Million
TABLE 30 Global Reagents & Kits Market by Region, 2022 - 2028, USD Million
TABLE 31 Global Instruments Market by Region, 2018 - 2021, USD Million
TABLE 32 Global Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 33 Global Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 34 Global Troponin I & T Market by Region, 2018 - 2021, USD Million
TABLE 35 Global Troponin I & T Market by Region, 2022 - 2028, USD Million
TABLE 36 Global Creatine kinase-MB(CK-MB) Market by Region, 2018 - 2021, USD Million
TABLE 37 Global Creatine kinase-MB(CK-MB) Market by Region, 2022 - 2028, USD Million
TABLE 38 Global Natriuretic peptide (Bnp Or Nt-Probnp) Market by Region, 2018 - 2021, USD Million
TABLE 39 Global Natriuretic peptide (Bnp Or Nt-Probnp) Market by Region, 2022 - 2028, USD Million
TABLE 40 Global Myoglobin Market by Region, 2018 - 2021, USD Million
TABLE 41 Global Myoglobin Market by Region, 2022 - 2028, USD Million
TABLE 42 Global High-sensitivity C-reactive protein(hs-CRP) Market by Region, 2018 - 2021, USD Million
TABLE 43 Global High-sensitivity C-reactive protein(hs-CRP) Market by Region, 2022 - 2028, USD Million
TABLE 44 Global Others Market by Region, 2018 - 2021, USD Million
TABLE 45 Global Others Market by Region, 2022 - 2028, USD Million
TABLE 46 Global Cardiac Marker Testing Market by Region, 2018 - 2021, USD Million
TABLE 47 Global Cardiac Marker Testing Market by Region, 2022 - 2028, USD Million
TABLE 48 North America Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 49 North America Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 50 North America Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 51 North America Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 52 North America Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 53 North America Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 54 North America Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
TABLE 55 North America Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
TABLE 56 North America Atherosclerosis Market by Country, 2018 - 2021, USD Million
TABLE 57 North America Atherosclerosis Market by Country, 2022 - 2028, USD Million
TABLE 58 North America Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 59 North America Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 60 North America Ischemia Market by Country, 2018 - 2021, USD Million
TABLE 61 North America Ischemia Market by Country, 2022 - 2028, USD Million
TABLE 62 North America Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 63 North America Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 64 North America Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 65 North America Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 66 North America Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 67 North America Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 68 North America Academic Institutions Market by Country, 2018 - 2021, USD Million
TABLE 69 North America Academic Institutions Market by Country, 2022 - 2028, USD Million
TABLE 70 North America Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 71 North America Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 72 North America Reagents & Kits Market by Country, 2018 - 2021, USD Million
TABLE 73 North America Reagents & Kits Market by Country, 2022 - 2028, USD Million
TABLE 74 North America Instruments Market by Country, 2018 - 2021, USD Million
TABLE 75 North America Instruments Market by Country, 2022 - 2028, USD Million
TABLE 76 North America Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 77 North America Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 78 North America Troponin I & T Market by Country, 2018 - 2021, USD Million
TABLE 79 North America Troponin I & T Market by Country, 2022 - 2028, USD Million
TABLE 80 North America Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
TABLE 81 North America Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
TABLE 82 North America Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
TABLE 83 North America Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
TABLE 84 North America Myoglobin Market by Country, 2018 - 2021, USD Million
TABLE 85 North America Myoglobin Market by Country, 2022 - 2028, USD Million
TABLE 86 North America High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
TABLE 87 North America High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
TABLE 88 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 89 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 90 North America Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
TABLE 91 North America Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
TABLE 92 US Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 93 US Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 94 US Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 95 US Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 96 US Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 97 US Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 98 US Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 99 US Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 100 US Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 101 US Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 102 Canada Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 103 Canada Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 104 Canada Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 105 Canada Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 106 Canada Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 107 Canada Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 108 Canada Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 109 Canada Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 110 Canada Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 111 Canada Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 112 Mexico Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 113 Mexico Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 114 Mexico Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 115 Mexico Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 116 Mexico Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 117 Mexico Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 118 Mexico Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 119 Mexico Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 120 Mexico Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 121 Mexico Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 122 Rest of North America Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 123 Rest of North America Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 124 Rest of North America Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 125 Rest of North America Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 126 Rest of North America Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 127 Rest of North America Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 128 Rest of North America Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 129 Rest of North America Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 130 Rest of North America Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 131 Rest of North America Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 132 Europe Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 133 Europe Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 134 Europe Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 135 Europe Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 136 Europe Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 137 Europe Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 138 Europe Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
TABLE 139 Europe Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
TABLE 140 Europe Atherosclerosis Market by Country, 2018 - 2021, USD Million
TABLE 141 Europe Atherosclerosis Market by Country, 2022 - 2028, USD Million
TABLE 142 Europe Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 143 Europe Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 144 Europe Ischemia Market by Country, 2018 - 2021, USD Million
TABLE 145 Europe Ischemia Market by Country, 2022 - 2028, USD Million
TABLE 146 Europe Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 147 Europe Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 148 Europe Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 149 Europe Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 150 Europe Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 151 Europe Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 152 Europe Academic Institutions Market by Country, 2018 - 2021, USD Million
TABLE 153 Europe Academic Institutions Market by Country, 2022 - 2028, USD Million
TABLE 154 Europe Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 155 Europe Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 156 Europe Reagents & Kits Market by Country, 2018 - 2021, USD Million
TABLE 157 Europe Reagents & Kits Market by Country, 2022 - 2028, USD Million
TABLE 158 Europe Instruments Market by Country, 2018 - 2021, USD Million
TABLE 159 Europe Instruments Market by Country, 2022 - 2028, USD Million
TABLE 160 Europe Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 161 Europe Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 162 Europe Troponin I & T Market by Country, 2018 - 2021, USD Million
TABLE 163 Europe Troponin I & T Market by Country, 2022 - 2028, USD Million
TABLE 164 Europe Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
TABLE 165 Europe Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
TABLE 166 Europe Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
TABLE 167 Europe Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
TABLE 168 Europe Myoglobin Market by Country, 2018 - 2021, USD Million
TABLE 169 Europe Myoglobin Market by Country, 2022 - 2028, USD Million
TABLE 170 Europe High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
TABLE 171 Europe High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
TABLE 172 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 173 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 174 Europe Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
TABLE 175 Europe Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
TABLE 176 Germany Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 177 Germany Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 178 Germany Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 179 Germany Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 180 Germany Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 181 Germany Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 182 Germany Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 183 Germany Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 184 Germany Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 185 Germany Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 186 UK Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 187 UK Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 188 UK Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 189 UK Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 190 UK Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 191 UK Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 192 UK Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 193 UK Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 194 UK Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 195 UK Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 196 France Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 197 France Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 198 France Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 199 France Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 200 France Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 201 France Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 202 France Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 203 France Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 204 France Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 205 France Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 206 Russia Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 207 Russia Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 208 Russia Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 209 Russia Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 210 Russia Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 211 Russia Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 212 Russia Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 213 Russia Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 214 Russia Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 215 Russia Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 216 Spain Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 217 Spain Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 218 Spain Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 219 Spain Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 220 Spain Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 221 Spain Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 222 Spain Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 223 Spain Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 224 Spain Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 225 Spain Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 226 Italy Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 227 Italy Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 228 Italy Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 229 Italy Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 230 Italy Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 231 Italy Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 232 Italy Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 233 Italy Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 234 Italy Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 235 Italy Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 236 Rest of Europe Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 237 Rest of Europe Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 238 Rest of Europe Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 239 Rest of Europe Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 240 Rest of Europe Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 241 Rest of Europe Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 242 Rest of Europe Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 243 Rest of Europe Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 244 Rest of Europe Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 245 Rest of Europe Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 246 Asia Pacific Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 247 Asia Pacific Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 248 Asia Pacific Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 249 Asia Pacific Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 250 Asia Pacific Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 251 Asia Pacific Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 252 Asia Pacific Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
TABLE 253 Asia Pacific Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
TABLE 254 Asia Pacific Atherosclerosis Market by Country, 2018 - 2021, USD Million
TABLE 255 Asia Pacific Atherosclerosis Market by Country, 2022 - 2028, USD Million
TABLE 256 Asia Pacific Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 257 Asia Pacific Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 258 Asia Pacific Ischemia Market by Country, 2018 - 2021, USD Million
TABLE 259 Asia Pacific Ischemia Market by Country, 2022 - 2028, USD Million
TABLE 260 Asia Pacific Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 261 Asia Pacific Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 262 Asia Pacific Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 263 Asia Pacific Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 264 Asia Pacific Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 265 Asia Pacific Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 266 Asia Pacific Academic Institutions Market by Country, 2018 - 2021, USD Million
TABLE 267 Asia Pacific Academic Institutions Market by Country, 2022 - 2028, USD Million
TABLE 268 Asia Pacific Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 269 Asia Pacific Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 270 Asia Pacific Reagents & Kits Market by Country, 2018 - 2021, USD Million
TABLE 271 Asia Pacific Reagents & Kits Market by Country, 2022 - 2028, USD Million
TABLE 272 Asia Pacific Instruments Market by Country, 2018 - 2021, USD Million
TABLE 273 Asia Pacific Instruments Market by Country, 2022 - 2028, USD Million
TABLE 274 Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 275 Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 276 Asia Pacific Troponin I & T Market by Country, 2018 - 2021, USD Million
TABLE 277 Asia Pacific Troponin I & T Market by Country, 2022 - 2028, USD Million
TABLE 278 Asia Pacific Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
TABLE 279 Asia Pacific Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
TABLE 280 Asia Pacific Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
TABLE 281 Asia Pacific Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
TABLE 282 Asia Pacific Myoglobin Market by Country, 2018 - 2021, USD Million
TABLE 283 Asia Pacific Myoglobin Market by Country, 2022 - 2028, USD Million
TABLE 284 Asia Pacific High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
TABLE 285 Asia Pacific High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
TABLE 286 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 287 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 288 Asia Pacific Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
TABLE 289 Asia Pacific Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
TABLE 290 China Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 291 China Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 292 China Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 293 China Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 294 China Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 295 China Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 296 China Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 297 China Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 298 China Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 299 China Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 300 Japan Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 301 Japan Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 302 Japan Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 303 Japan Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 304 Japan Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 305 Japan Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 306 Japan Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 307 Japan Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 308 Japan Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 309 Japan Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 310 India Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 311 India Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 312 India Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 313 India Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 314 India Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 315 India Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 316 India Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 317 India Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 318 India Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 319 India Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 320 South Korea Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 321 South Korea Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 322 South Korea Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 323 South Korea Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 324 South Korea Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 325 South Korea Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 326 South Korea Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 327 South Korea Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 328 South Korea Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 329 South Korea Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 330 Singapore Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 331 Singapore Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 332 Singapore Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 333 Singapore Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 334 Singapore Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 335 Singapore Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 336 Singapore Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 337 Singapore Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 338 Singapore Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 339 Singapore Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 340 Malaysia Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 341 Malaysia Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 342 Malaysia Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 343 Malaysia Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 344 Malaysia Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 345 Malaysia Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 346 Malaysia Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 347 Malaysia Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 348 Malaysia Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 349 Malaysia Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 350 Rest of Asia Pacific Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 351 Rest of Asia Pacific Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 352 Rest of Asia Pacific Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 353 Rest of Asia Pacific Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 354 Rest of Asia Pacific Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 355 Rest of Asia Pacific Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 356 Rest of Asia Pacific Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 357 Rest of Asia Pacific Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 358 Rest of Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 359 Rest of Asia Pacific Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 360 LAMEA Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 361 LAMEA Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 362 LAMEA Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 363 LAMEA Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 364 LAMEA Myocardial Infarction Market by Country, 2018 - 2021, USD Million
TABLE 365 LAMEA Myocardial Infarction Market by Country, 2022 - 2028, USD Million
TABLE 366 LAMEA Congestive Heart Failure Market by Country, 2018 - 2021, USD Million
TABLE 367 LAMEA Congestive Heart Failure Market by Country, 2022 - 2028, USD Million
TABLE 368 LAMEA Atherosclerosis Market by Country, 2018 - 2021, USD Million
TABLE 369 LAMEA Atherosclerosis Market by Country, 2022 - 2028, USD Million
TABLE 370 LAMEA Acute Coronary Syndrome Market by Country, 2018 - 2021, USD Million
TABLE 371 LAMEA Acute Coronary Syndrome Market by Country, 2022 - 2028, USD Million
TABLE 372 LAMEA Ischemia Market by Country, 2018 - 2021, USD Million
TABLE 373 LAMEA Ischemia Market by Country, 2022 - 2028, USD Million
TABLE 374 LAMEA Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 375 LAMEA Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 376 LAMEA Laboratory Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 377 LAMEA Laboratory Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 378 LAMEA Point-of-Care Testing Facilities Market by Country, 2018 - 2021, USD Million
TABLE 379 LAMEA Point-of-Care Testing Facilities Market by Country, 2022 - 2028, USD Million
TABLE 380 LAMEA Academic Institutions Market by Country, 2018 - 2021, USD Million
TABLE 381 LAMEA Academic Institutions Market by Country, 2022 - 2028, USD Million
TABLE 382 LAMEA Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 383 LAMEA Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 384 LAMEA Reagents & Kits Market by Country, 2018 - 2021, USD Million
TABLE 385 LAMEA Reagents & Kits Market by Country, 2022 - 2028, USD Million
TABLE 386 LAMEA Instruments Market by Country, 2018 - 2021, USD Million
TABLE 387 LAMEA Instruments Market by Country, 2022 - 2028, USD Million
TABLE 388 LAMEA Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 389 LAMEA Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 390 LAMEA Troponin I & T Market by Country, 2018 - 2021, USD Million
TABLE 391 LAMEA Troponin I & T Market by Country, 2022 - 2028, USD Million
TABLE 392 LAMEA Creatine kinase-MB(CK-MB) Market by Country, 2018 - 2021, USD Million
TABLE 393 LAMEA Creatine kinase-MB(CK-MB) Market by Country, 2022 - 2028, USD Million
TABLE 394 LAMEA Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2018 - 2021, USD Million
TABLE 395 LAMEA Natriuretic peptide (Bnp Or Nt-Probnp) Market by Country, 2022 - 2028, USD Million
TABLE 396 LAMEA Myoglobin Market by Country, 2018 - 2021, USD Million
TABLE 397 LAMEA Myoglobin Market by Country, 2022 - 2028, USD Million
TABLE 398 LAMEA High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2018 - 2021, USD Million
TABLE 399 LAMEA High-sensitivity C-reactive protein(hs-CRP) Market by Country, 2022 - 2028, USD Million
TABLE 400 LAMEA Others Market by Country, 2018 - 2021, USD Million
TABLE 401 LAMEA Others Market by Country, 2022 - 2028, USD Million
TABLE 402 LAMEA Cardiac Marker Testing Market by Country, 2018 - 2021, USD Million
TABLE 403 LAMEA Cardiac Marker Testing Market by Country, 2022 - 2028, USD Million
TABLE 404 Brazil Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 405 Brazil Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 406 Brazil Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 407 Brazil Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 408 Brazil Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 409 Brazil Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 410 Brazil Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 411 Brazil Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 412 Brazil Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 413 Brazil Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 414 Argentina Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 415 Argentina Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 416 Argentina Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 417 Argentina Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 418 Argentina Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 419 Argentina Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 420 Argentina Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 421 Argentina Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 422 Argentina Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 423 Argentina Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 424 UAE Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 425 UAE Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 426 UAE Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 427 UAE Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 428 UAE Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 429 UAE Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 430 UAE Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 431 UAE Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 432 UAE Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 433 UAE Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 434 Saudi Arabia Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 435 Saudi Arabia Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 436 Saudi Arabia Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 437 Saudi Arabia Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 438 Saudi Arabia Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 439 Saudi Arabia Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 440 Saudi Arabia Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 441 Saudi Arabia Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 442 Saudi Arabia Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 443 Saudi Arabia Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 444 South Africa Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 445 South Africa Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 446 South Africa Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 447 South Africa Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 448 South Africa Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 449 South Africa Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 450 South Africa Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 451 South Africa Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 452 South Africa Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 453 South Africa Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 454 Nigeria Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 455 Nigeria Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 456 Nigeria Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 457 Nigeria Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 458 Nigeria Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 459 Nigeria Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 460 Nigeria Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 461 Nigeria Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 462 Nigeria Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 463 Nigeria Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 464 Rest of LAMEA Cardiac Marker Testing Market, 2018 - 2021, USD Million
TABLE 465 Rest of LAMEA Cardiac Marker Testing Market, 2022 - 2028, USD Million
TABLE 466 Rest of LAMEA Cardiac Marker Testing Market by Disease, 2018 - 2021, USD Million
TABLE 467 Rest of LAMEA Cardiac Marker Testing Market by Disease, 2022 - 2028, USD Million
TABLE 468 Rest of LAMEA Cardiac Marker Testing Market by End User, 2018 - 2021, USD Million
TABLE 469 Rest of LAMEA Cardiac Marker Testing Market by End User, 2022 - 2028, USD Million
TABLE 470 Rest of LAMEA Cardiac Marker Testing Market by Product, 2018 - 2021, USD Million
TABLE 471 Rest of LAMEA Cardiac Marker Testing Market by Product, 2022 - 2028, USD Million
TABLE 472 Rest of LAMEA Cardiac Marker Testing Market by Biomarker Type, 2018 - 2021, USD Million
TABLE 473 Rest of LAMEA Cardiac Marker Testing Market by Biomarker Type, 2022 - 2028, USD Million
TABLE 474 Key Information – Abbott Laboratories
TABLE 475 Key Information – Siemens Healthineers AG
TABLE 476 Key information – Becton, Dickinson and Company
TABLE 477 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 478 Key Information – Thermo Fisher Scientific, Inc.
TABLE 479 Key Information – Bio-Rad Laboratories, Inc.
TABLE 480 Key Information – Danaher Corporation
TABLE 481 Key Information – DiaSorin S.p.A.
TABLE 482 key Information – PerkinElmer, Inc.
TABLE 483 Key information – BioMérieux S.A.
,
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Global Cardiac Marker Testing Market Share by Disease, 2021
FIG 5 Global Cardiac Marker Testing Market Share by Disease, 2028
FIG 6 Global Cardiac Marker Testing Market by Disease, 2018 - 2028, USD Million
FIG 7 Global Cardiac Marker Testing Market Share by End User, 2021
FIG 8 Global Cardiac Marker Testing Market Share by End User, 2028
FIG 9 Global Cardiac Marker Testing Market by End User, 2018 - 2028, USD Million
FIG 10 Global Cardiac Marker Testing Market Share by Product, 2021
FIG 11 Global Cardiac Marker Testing Market Share by Product, 2028
FIG 12 Global Cardiac Marker Testing Market by Product, 2018 - 2028, USD Million
FIG 13 Global Cardiac Marker Testing Market Share by Biomarker Type, 2021
FIG 14 Global Cardiac Marker Testing Market Share by Biomarker Type, 2028
FIG 15 Global Cardiac Marker Testing Market by Biomarker Type, 2018 - 2028, USD Million
FIG 16 Global Cardiac Marker Testing Market Share by Region, 2021
FIG 17 Global Cardiac Marker Testing Market Share by Region, 2028
FIG 18 Global Cardiac Marker Testing Market by Region, 2018 - 2028, USD Million
FIG 19 Recent strategies and developments: Abbott Laboratories
FIG 20 Swot analysis: Abbott laboratories
FIG 21 Recent strategies and developments: Siemens Healthineers AG
FIG 22 Swot analysis: Siemens AG
FIG 23 Recent strategies and developments: Thermo Fisher Scientific, Inc.